Article Details
Retrieved on: 2022-10-25 12:55:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Reuters) -Drugmaker AstraZeneca said on Tuesday that its asthma drug Fasenra failed to meet one of two main goals of a late-stage study assessing ...
Article found on: www.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here